Skip to main content
Top
Published in: Clinical Rheumatology 12/2015

01-12-2015 | Original Article

Rhupus; unusual presentations

Authors: Ora Shovman, Pnina Langevitz, Yehuda Shoenfeld

Published in: Clinical Rheumatology | Issue 12/2015

Login to get access

Abstract

Background

The coexistence of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) named Rhupus is an unusual clinical condition. Previous reports mentioned that Rhupus patients have prominent RA-associated clinical manifestations and only mild organic damage related to SLE. Progressive or life-threatening manifestations are rare in Rhupus patients.

Methods

Three patients with Rhupus are described in this article. Two of them presented antiphospholipid syndrome (APS) in addition to Rhupus. Also, we searched for similar cases in published literature.

Results

We present three patients with Rhupus syndrome. One of the patients has only Rhupus, the second patient has Rhupus and APS, and the third patient has Rhupus accompanied by severe Raynaud’s syndrome with digital ulcers, APS, pulmonary hypertension and two malignancies.
Several studies have shown that Rhupus patients have an increased prevalence of positive antiphospholipid antibodies that resembles SLE. However, the presence of these antibodies is not associated with APS. There is only one case of Rhupus with secondary APS in which the patient presented headache and papilloedema due to cerebral venous thrombosis. Secondary Raynaud’s syndrome is rare in Rhupus patients, and to the best of our knowledge, only three cases of this are mentioned in literature. Secondary pulmonary hypertension and malignancies were never reported before in Rhupus patients.

Conclusions

Rheumatologists should be aware of the possibility that Rhupus may be accompanied by progressive or life-threatening conditions such as APS, severe Raynaud’s syndrome with digital ulcers, pulmonary hypertension, or malignancies.
Literature
1.
go back to reference Schur PH (1971) Systemic lupus erythematosus. In: Beeson PB, McDermott W (eds) Cecil-Loeb texbook of medicine. Sanders, Philadelphia, p 821 Schur PH (1971) Systemic lupus erythematosus. In: Beeson PB, McDermott W (eds) Cecil-Loeb texbook of medicine. Sanders, Philadelphia, p 821
2.
go back to reference Simón JA, Granados J, Cabiedes J, Morales JR, Varela JA (2002) Clinical and immunogenetic characterization of Mexican patients with ‘rhupus’. Lupus 11:287–292CrossRefPubMed Simón JA, Granados J, Cabiedes J, Morales JR, Varela JA (2002) Clinical and immunogenetic characterization of Mexican patients with ‘rhupus’. Lupus 11:287–292CrossRefPubMed
3.
go back to reference Fernández A, Quintana G, Matteson EL, Restrepo JF, Rondón F, Sánchez A et al (2004) Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol 23:523–526CrossRefPubMed Fernández A, Quintana G, Matteson EL, Restrepo JF, Rondón F, Sánchez A et al (2004) Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol 23:523–526CrossRefPubMed
4.
go back to reference Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F (2011) Extra-articularmanifestations of rheumatoid arthritis: an update. Autoimmun Rev 11:123–131CrossRefPubMed Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F (2011) Extra-articularmanifestations of rheumatoid arthritis: an update. Autoimmun Rev 11:123–131CrossRefPubMed
5.
go back to reference Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M et al (2013) Overlap connective tissue disease syndromes. Autoimmun Rev 12:363–373CrossRefPubMed Iaccarino L, Gatto M, Bettio S, Caso F, Rampudda M, Zen M et al (2013) Overlap connective tissue disease syndromes. Autoimmun Rev 12:363–373CrossRefPubMed
6.
go back to reference Panush RS, Edwards NL, Longley S, Webster E (1988) ‘Rhupus’ syndrome. Arch Intern Med 148:1633–1636CrossRefPubMed Panush RS, Edwards NL, Longley S, Webster E (1988) ‘Rhupus’ syndrome. Arch Intern Med 148:1633–1636CrossRefPubMed
8.
go back to reference Brand CA, Rowley MJ, Tait BD, Muirden KD, Whittingham SF (1992) Coexistent rheumatoid arthritis and systemic lupus erythematosus; clinical, serological, and phenotypic features. Ann Rheum Dis 51:173–176PubMedCentralCrossRefPubMed Brand CA, Rowley MJ, Tait BD, Muirden KD, Whittingham SF (1992) Coexistent rheumatoid arthritis and systemic lupus erythematosus; clinical, serological, and phenotypic features. Ann Rheum Dis 51:173–176PubMedCentralCrossRefPubMed
9.
go back to reference Li J, Wu H, Huang X, Xu D, Zheng W, Zhao Y et al (2014) Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study. Medicine (Baltimore) 93 Li J, Wu H, Huang X, Xu D, Zheng W, Zhao Y et al (2014) Clinical analysis of 56 patients with rhupus syndrome: manifestations and comparisons with systemic lupus erythematosus: a retrospective case-control study. Medicine (Baltimore) 93
10.
go back to reference Hayakawa S, Komine-Aizawa S, Osaka S, Iida T, Hayakawa J, Nishinarita S et al (2007) Rembrandt’s Maria Bockenolle has a butterfly rash and digital deformities: overlapping syndrome of rheumatoid arthritis and systemic lupus erythematosus. Med Hypotheses 68(4):906–909CrossRefPubMed Hayakawa S, Komine-Aizawa S, Osaka S, Iida T, Hayakawa J, Nishinarita S et al (2007) Rembrandt’s Maria Bockenolle has a butterfly rash and digital deformities: overlapping syndrome of rheumatoid arthritis and systemic lupus erythematosus. Med Hypotheses 68(4):906–909CrossRefPubMed
11.
go back to reference Liu T, Li G, Mu R, Ye H, Li W, Li Z (2014) Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus 23:958–963CrossRefPubMed Liu T, Li G, Mu R, Ye H, Li W, Li Z (2014) Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus 23:958–963CrossRefPubMed
12.
go back to reference Tani C, D’Aniello D, Delle Sedie A, Carli L, Cagnoni M, Possemato N et al (2013) Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev 12:537–541CrossRefPubMed Tani C, D’Aniello D, Delle Sedie A, Carli L, Cagnoni M, Possemato N et al (2013) Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev 12:537–541CrossRefPubMed
13.
go back to reference Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 29:421–425CrossRefPubMed Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 29:421–425CrossRefPubMed
14.
go back to reference Mosca M, Tani C, Carli L, Bombardieri S (2011) Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 29:S126–S129PubMed Mosca M, Tani C, Carli L, Bombardieri S (2011) Glucocorticoids in systemic lupus erythematosus. Clin Exp Rheumatol 29:S126–S129PubMed
15.
go back to reference Agmon-Levin N, Mosca M, Petri M (2012) Systemic lupus erythematosus one disease or many? Autoimmun Rev 11:593–595CrossRefPubMed Agmon-Levin N, Mosca M, Petri M (2012) Systemic lupus erythematosus one disease or many? Autoimmun Rev 11:593–595CrossRefPubMed
16.
go back to reference Satoh M, Ajmani AK, Akizuki M (1994) What is the definition for coexistent rheumatoid arthritis and systemic lupus erythematosus? Lupus 3:137–138CrossRefPubMed Satoh M, Ajmani AK, Akizuki M (1994) What is the definition for coexistent rheumatoid arthritis and systemic lupus erythematosus? Lupus 3:137–138CrossRefPubMed
17.
go back to reference Piga M, Gabba A, Cauli A, Garau P, Vacca A, Mathieu A (2013) Rituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus 22:624–628CrossRefPubMed Piga M, Gabba A, Cauli A, Garau P, Vacca A, Mathieu A (2013) Rituximab treatment for ‘rhupus syndrome’: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus 22:624–628CrossRefPubMed
18.
go back to reference Ostendorf B, Scherer A, Specker C (2003) Jaccoud’s arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 48:157–165CrossRefPubMed Ostendorf B, Scherer A, Specker C (2003) Jaccoud’s arthropathy in systemic lupus erythematosus: differentiation of deforming and erosive patterns by magnetic resonance imaging. Arthritis Rheum 48:157–165CrossRefPubMed
19.
go back to reference Fernández A, Quintana G, Rondón F, Restrepo JF, Sánchez A, Matteson EL et al (2006) Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol 25:164–167CrossRefPubMed Fernández A, Quintana G, Rondón F, Restrepo JF, Sánchez A, Matteson EL et al (2006) Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol 25:164–167CrossRefPubMed
21.
go back to reference Wang JG, Tang HH, Tan CY, Liu Y, Lin H, Chen YT (2010) Diffuse lupus encephalopathy in a case of rhupus syndrome. Rheumatol Int 30:961–963CrossRefPubMed Wang JG, Tang HH, Tan CY, Liu Y, Lin H, Chen YT (2010) Diffuse lupus encephalopathy in a case of rhupus syndrome. Rheumatol Int 30:961–963CrossRefPubMed
22.
go back to reference Chowdhury SR, Majumder S, Chakraborty PP, Mandal SK, Bandyopadhyay R, Bandyopadhyay D et al (2008) Headache in a case of Rhupus syndrome. Headache 48:155–158CrossRefPubMed Chowdhury SR, Majumder S, Chakraborty PP, Mandal SK, Bandyopadhyay R, Bandyopadhyay D et al (2008) Headache in a case of Rhupus syndrome. Headache 48:155–158CrossRefPubMed
23.
go back to reference Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed Alarcón-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334PubMed
24.
go back to reference Turesson C, Matteson EL (2013) Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) 52:5–14CrossRef Turesson C, Matteson EL (2013) Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford) 52:5–14CrossRef
25.
go back to reference Skare TL, Nisihara R, Barbosa BB, da Luz A, Utiyama S, Picceli V (2013) Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients. Clin Rheumatol 32:1065–1070CrossRefPubMed Skare TL, Nisihara R, Barbosa BB, da Luz A, Utiyama S, Picceli V (2013) Anti-CCP in systemic lupus erythematosus patients: a cross sectional study in Brazilian patients. Clin Rheumatol 32:1065–1070CrossRefPubMed
26.
go back to reference Liao KP, Kurreeman F, Li G, Duclos G, Murphy S, Guzman R et al (2013) Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum 65:571–581PubMedCentralCrossRefPubMed Liao KP, Kurreeman F, Li G, Duclos G, Murphy S, Guzman R et al (2013) Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum 65:571–581PubMedCentralCrossRefPubMed
27.
go back to reference Mawson AR (1985) Are rheumatoid arthritis and systemic lupus erythematosus inversely related diseases? Med Hypotheses 18:377–386CrossRefPubMed Mawson AR (1985) Are rheumatoid arthritis and systemic lupus erythematosus inversely related diseases? Med Hypotheses 18:377–386CrossRefPubMed
28.
go back to reference Sundaramurthy SG, Karsevar MP, van Vollenhoven RF (1999) Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritis. J Clin Rheumatol 5:9–16CrossRefPubMed Sundaramurthy SG, Karsevar MP, van Vollenhoven RF (1999) Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritis. J Clin Rheumatol 5:9–16CrossRefPubMed
29.
go back to reference Pipili C, Sfritzeri A, Cholongitas E (2008) Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med 19:482–487CrossRefPubMed Pipili C, Sfritzeri A, Cholongitas E (2008) Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med 19:482–487CrossRefPubMed
30.
go back to reference Aringer M, Smolen JS (2012) Therapeutic blockade of TNF in patients with SLE-promising or crazy? Autoimmun Rev 11:321–325CrossRefPubMed Aringer M, Smolen JS (2012) Therapeutic blockade of TNF in patients with SLE-promising or crazy? Autoimmun Rev 11:321–325CrossRefPubMed
31.
go back to reference Andrade-Ortega L, Irazoque-Palazuelos F, Muñóz-López S, Rosales-Don Pablo VM (2013) Efficacy and tolerability of rituximab in patients with rhupus. Reumatol Clin 9:201–205CrossRefPubMed Andrade-Ortega L, Irazoque-Palazuelos F, Muñóz-López S, Rosales-Don Pablo VM (2013) Efficacy and tolerability of rituximab in patients with rhupus. Reumatol Clin 9:201–205CrossRefPubMed
32.
go back to reference Ikeda K, Sanayama Y, Makita S, Hosokawa J, Yamagata M, Nakagomi D et al (2013) Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol. 2013: Article ID 697525 Ikeda K, Sanayama Y, Makita S, Hosokawa J, Yamagata M, Nakagomi D et al (2013) Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol. 2013: Article ID 697525
Metadata
Title
Rhupus; unusual presentations
Authors
Ora Shovman
Pnina Langevitz
Yehuda Shoenfeld
Publication date
01-12-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2978-y

Other articles of this Issue 12/2015

Clinical Rheumatology 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.